An Official Website of the United States Government
Company Information:
Name:
Immunicon Corporation
Address:
Immunicon Corporation
3401 Masons Mill Rd, Ste 100
Huntingdon Valley, PA 19006
3401 Masons Mill Rd, Ste 100
Huntingdon Valley, PA 19006
Located in HUBZone:
No
Woman-Owned:
No
Minority-Owned:
No
URL:
N/A
Phone:
(215) 830-0777
Award Totals:
Award List:
FEASIBILITY STUDIES FOR DEVELOPING A NOVEL CLINICAL DEVICE ARE PROPOSED.
Award Year / Program / Phase:
1985 / SBIR / Phase I
Agency:
HHS
Principal Investigator:
Paul a. liberti , PRINCIPAL INVESTIGATOR
Award Amount:
$50,000.00
Abstract:
Feasibility studies for developing a novel clinical device are proposed. this device which would use immunological and complement reagents in conjunction with filtration and/or one or more magnetic retrieval systems to produce a new separation and collection technology could result in totally new… More
BIOPROCESSING CELLS FROM BLOOD USING BR-FF AND HGMS
Award Year / Program / Phase:
1991 / SBIR / Phase I
Agency:
HHS
Principal Investigator:
Liberti, Paul A , Principal Investigator
Award Amount:
$50,000.00
Abstract:
The long term objective is to develop a new technology for industry scale affinity separations employing proprietary bio-receptor ferrofluids (br-ff) in combination with existing continuous high gradient magnetic separators (hgms) and improved systems currently being developed. br-ff are being used… More
BIOPROCESSING USING BIORECEPTOR FERROFLUIDS AND HGMS
Award Year / Program / Phase:
1991 / SBIR / Phase I
Agency:
HHS
Principal Investigator:
Liberti, Paul A , Principal Investigator
Award Amount:
$50,000.00
BIOPROCESSING USING BIORECEPTOR FERROFLUIDS AND HGMS
Award Year / Program / Phase:
1992 / SBIR / Phase II
Agency:
HHS
Principal Investigator:
Liberti, Paul A , Principal Investigator
Award Amount:
$383,836.00
Abstract:
The long-term objective is to develop a new technology for industry scale affinity separations employing proprietary bio- receptor ferrofluids (br-ff) in combination with existing high gradient magnetic separators (hgms) and improved systems currently being developed. br-ff are being used… More
N/A
Award Year / Program / Phase:
2000 / SBIR / Phase I
Agency:
HHS
Principal Investigator:
Chandra Rao
Award Amount:
$100,000.00
Analysis of Circulating Cancer Cells Early in Disease
Award Year / Program / Phase:
2001 / SBIR / Phase I
Agency:
HHS
Principal Investigator:
Chandra Rao
Award Amount:
$0.00
Abstract:
DESCRIPTION: (provided by applicant)
The long term objective of this proposal is commercialization of a test for
the management of cancer. Immunicon has developed a sensitive test for
detecting tumor cells in peripheral blood. … More
Analysis of Circulating Cancer Cells Early in Disease
Award Year / Program / Phase:
2001 / SBIR / Phase II
Agency:
HHS
Principal Investigator:
Chandra Rao
Award Amount:
$309,500.00
Abstract:
DESCRIPTION: (provided by applicant)
The long term objective of this proposal is commercialization of a test for
the management of cancer. Immunicon has developed a sensitive test for
detecting tumor cells in peripheral blood. … More
Gene Expression in Circulating Tumor Cells
Award Year / Program / Phase:
2003 / STTR / Phase I
Agency:
HHS
Research Institution:
FOX CHASE CANCER CENTER